For: | Alqahtani SA, Colombo MG. Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma . World J Gastrointest Oncol 2021; 13(12): 2038-2049 [PMID: 35070040 DOI: 10.4251/wjgo.v13.i12.2038] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i12/2038.htm |
Number | Citing Articles |
1 |
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Mariateresa Cristani, Francesco Cimino, Antonella Saija. Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy. Molecules 2022; 27(6): 1775 doi: 10.3390/molecules27061775
|
2 |
Haiyuan Li, Lei Gao, Xiaojuan Kang, Xueyan Wang, Yang Yu, Yaqing Zhang, Hao Chen. RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(1): 806 doi: 10.3390/ijms24010806
|
3 |
Yan Jiao, Ye Gao, JiaYao Wang, Huanxiao An, Yi Xiang Li, Xi Zhang. Intelligent porphyrin nano-delivery system for photostimulated and targeted inhibition of angiogenesis. International Journal of Pharmaceutics 2022; 621: 121805 doi: 10.1016/j.ijpharm.2022.121805
|